Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesCost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
British Journal of Cancer, 06/04/09
Shiroiwa T et al. - Capecitabine plus oxaliplatin (XELOX) as first-line and second-line chemotherapy was 'dominant'. In terms of effectiveness and cost, XELOX was superior to FOLFOX4.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Joint Extraintestinal Manifestations in Ulcerative Colitis
Digestive Diseases, 11/09/09
The liver in 30-year-old individuals with alpha 1 -antitrypsin deficiency
Scandinavian Journal of Gastroenterology, 11/06/09
Caspase-cleaved fragments of cytokeratin 18 - the promises and challenges of a biomarker for chronic liver disease
Alimentary Pharmacology and Therapeutics, 11/03/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Treatment of Fistulizing Inflammatory Bowel Disease
Gastroenterology Clinics of North America, 11/13/09
Capsule endoscopy in clinical practice: concise up-to-date overview
Clinical and Experimental Gastroenterology, 11/12/09
Sponsor
Article Search
Sponsor